REGENXBIO Inc. Financial Ratios — RGNX Stock

Profitability (USD)

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	-33.27	-42.45	28.89	-19.76	-26.87	22.39	-43.78	-63.65	-79.49	-107
Return on Assets (%)	- -	-133.41	-20.29	-31.95	-39.4	26.92	-18.19	-18.45	14.03	-28.79	-37.45	-43.68	-42.19
Return on Capital (%)	- -	- -	- -	- -	- -	28.65	- -	- -	23.3	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	24.21	- -	- -	22.01	- -	- -	- -	- -
Gross Margin (%)	94.68	83.55	80.19	79.1	83.56	95.59	76.61	76.89	88.98	51.61	58.76	59.72	88.09
EBITDA Margin (%)	-78.23	-60.16	-303.86	-1,411.99	-704.31	42.14	-402.59	-71.7	36.05	-221.75	-277.93	-258.05	-85.42
Operating Margin (%)	-78.23	-60.16	-304.92	-1,423.84	-730.15	40.32	-422.89	-77.14	34.01	-233.2	-297.12	-277.51	-94.58
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	78.8	- -	- -	88.42	- -	- -	- -	- -
Pretax Margin (%)	-88.5	-65.41	-300.62	-1,381.61	-704.02	47.65	-276.7	-68.59	30.03	-248.75	-292.15	-272.54	-113.75
Profit Margin (%)	-88.5	-65.41	-300.62	-1,372.13	-704.02	45.74	-268.88	-71.98	27.18	-248.68	-291.99	-272.54	-113.75
Net Income to Common Margin (%)	-95.43	-78.73	-323.64	-1,372.13	-704.02	45.74	-268.88	-71.98	27.18	-248.68	-291.99	-272.54	-113.75
Effective Tax Rate (%)	- -	- -	- -	- -	- -	4.01	- -	- -	9.49	- -	- -	- -	- -
Dvd Payout Ratio (%)	7.26	16.92	7.11	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	-33.27	-42.45	28.89	-19.76	-26.87	22.39	-43.78	-63.65	-79.49	-107

Credit (USD)

Credit Ratios API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	2	- -	- -	- -	6	11	73	87	95	89	82	74
ST Debt	- -	2	- -	- -	- -	- -	2	2	2	6	7	8	8
LT Debt	- -	- -	- -	- -	- -	6	9	70	85	89	82	74	65
Total Debt/EBITDA	- -	-0.65	- -	- -	- -	0.06	-0.08	-0.66	0.51	-0.38	-0.36	-0.38	-0.5
Net Debt/EBITDA	0.23	-0.35	2.35	0.38	0.64	-0.82	0.49	3.05	-2.04	0.39	0.14	0.27	0.24
Total Debt/EBIT	- -	-0.65	- -	- -	- -	0.07	-0.08	-0.61	0.54	-0.36	-0.33	-0.35	-0.46
Net Debt/EBIT	0.23	-0.35	2.34	0.38	0.61	-0.86	0.47	2.84	-2.16	0.37	0.13	0.25	0.21
EBITDA to Interest Expense	-7.79	-11.47	-1,152.85	- -	- -	- -	- -	-143.74	6.45	-10.75	-36.55	-16.99	-3.23
EBITDA-CapEx/Interest Expense	-7.79	-11.47	-1,178.95	- -	- -	- -	- -	-178.59	3.25	-12.07	-38	-17.18	-3.29
EBIT to Interest Expense	-7.79	-11.47	-1,156.85	- -	- -	- -	- -	-154.65	6.09	-11.3	-39.07	-18.27	-3.58
Interest Expense	1	- -	- -	- -	- -	- -	- -	1	26	23	7	13	45
Common Equity/Total Assets	-554.62	-523.95	97.93	93.63	92.12	93.57	90.42	53.34	68.61	61.95	54.31	55.72	22.68
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	1.15	1.97	18.57	11.11	17.2	26.38	28.55	63.48
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	1.14	1.92	15.58	9.98	14.53	20.5	21.7	37
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	1.08	1.78	9.91	7.62	10.66	14.33	15.91	14.4
Total Debt/Equity (%)	- -	-42.17	- -	- -	- -	1.15	2.51	19.23	11.34	18.36	28.64	31.59	71.55
Total Debt/Capital (%)	- -	-72.93	- -	- -	- -	1.14	2.45	16.13	10.19	15.52	22.27	24.01	41.71
Total Debt/Total Assets (%)	- -	68.83	- -	- -	- -	1.08	2.27	10.26	7.78	11.38	15.56	17.6	16.22
Net Debt to Equity	52.22	-22.5	-24.96	-15.36	-25.49	-14.85	-15.44	-89.59	-45.17	-18.78	-11.07	-22.16	-33.55
Net Debt/Capital (%)	34.3	-29.03	-33.26	-18.15	-34.21	-17.21	-17.73	-302.22	-68.25	-18.86	-9.42	-20.24	-24.31
EBITDA	-5	-4	-23	-65	-73	92	-142	-111	170	-250	-251	-215	-146
EBITDA-CapEx	-5	-4	-24	-73	-80	79	-154	-138	85	-281	-261	-217	-148
Operating Income (Loss)	-5	-4	-23	-65	-76	88	-149	-119	160	-263	-268	-231	-161

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.24	0.12	26.31	9.26	11.14	14.42	8.8	5.84	3.51	2.8	2.11	2.27	1.95
Current Ratio	0.47	0.33	27.23	9.66	11.64	15.24	10.25	6.52	3.98	3.19	2.57	2.69	2.38
Quick Ratio	0.47	0.33	26.8	9.37	11.17	14.81	9.93	6.37	3.75	3.03	2.32	2.48	2.18
CFO/Avg Current Liab	- -	-0.35	-3.33	-6.93	-4.81	5.72	-3.86	-0.94	2.07	-1.59	-1.68	-1.48	-1.12
Common Equity/Total Assets	-554.62	-523.95	97.93	93.63	92.12	93.57	90.42	53.34	68.61	61.95	54.31	55.72	22.68
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	1.15	1.97	18.57	11.11	17.2	26.38	28.55	63.48
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	1.14	1.92	15.58	9.98	14.53	20.5	21.7	37
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	1.08	1.78	9.91	7.62	10.66	14.33	15.91	14.4
Total Debt/Equity (%)	- -	-42.17	- -	- -	- -	1.15	2.51	19.23	11.34	18.36	28.64	31.59	71.55
Total Debt/Capital (%)	- -	-72.93	- -	- -	- -	1.14	2.45	16.13	10.19	15.52	22.27	24.01	41.71
Total Debt/Total Assets (%)	- -	68.83	- -	- -	- -	1.08	2.27	10.26	7.78	11.38	15.56	17.6	16.22
CFO/Total Liabilities	-64.73	-26.11	-492.45	-441.64	-370.6	299.29	-225.74	-16.36	62.61	-65.44	-83.29	-83.9	-35.39
CFO/CapEx	- -	- -	-43.13	-5.96	-8.1	7.88	-9.19	-2.01	2.6	-6.75	-21.93	-71.07	-51.35
Altman's Z-Score	-18.84	-15.4	57.3	25.23	38.3	27.42	18.39	2.94	3.52	0.62	-0.87	-2.7	-2.59

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	14.32	5.16	2.9	13.81	48.24	7.86	9.99	30.41	349.53	35.17	33.89	548.04
Days Sales Outstanding	- -	25.5	70.73	125.99	26.43	7.57	46.43	36.54	12	1.04	10.38	10.77	0.67
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	3.17	2.23	0.75	0.54	2.09	1.52	4.19	4.71	2.83	1.49	1.47	0.92
Accounts Payable Turnover Days	- -	115.08	163.68	486.6	680.77	175	239.64	87.03	77.49	129.15	245.21	247.84	397.01
Cash Conversion Cycle	- -	-89.59	-92.94	-360.61	-654.34	-167.44	-193.21	-50.49	-65.49	-128.11	-234.83	-237.07	-396.34
Inventory to Cash Days	- -	25.5	70.73	125.99	26.43	7.57	46.43	36.54	12	1.04	10.38	10.77	0.67
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	437	491	1,041	1,515	1,516	1,700	1,401	982	791	383	733
- Cash & Cash Equivalents	1	1	54	25	47	76	70	338	345	97	35	58	34
+ Preferred Equity and Hybrid Capital	12	13	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	2	- -	- -	- -	6	11	73	87	95	89	82	74
Enterprise Value	11	14	323	402	880	1,201	1,231	1,297	1,030	712	605	230	576
Total Capital	-2	-3	217	162	183	515	461	450	851	611	401	342	176
Total Debt/Capital (%)	- -	-72.93	- -	- -	- -	1.14	2.45	16.13	10.19	15.52	22.27	24.01	41.71
Total Debt / EV	- -	0.17	- -	- -	- -	- -	0.01	0.06	0.08	0.13	0.15	0.36	0.13
EV/Sales	1.75	2.27	42.52	87.51	84.65	5.5	34.93	8.39	2.19	6.32	6.7	2.76	3.38
EV/EBITDA	- -	- -	- -	- -	- -	13.05	- -	- -	6.07	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	13.64	- -	- -	6.44	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	11.48	- -	- -	4.24	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	10.19	- -	- -	3.15	- -	- -	- -	- -
Diluted Market Cap	- -	- -	152	490	993	1,537	1,503	1,691	1,436	979	785	383	743
Diluted Enterprise Value	11	14	98	465	947	1,468	1,445	1,425	1,177	977	840	407	782
EV per Share	0.43	0.56	12.26	15.17	28.11	33.26	33.27	34.6	24.04	16.45	13.73	4.65	11.32
TTM Sales	6	6	8	5	10	219	35	155	470	113	90	83	170
TTM EBITDA	-5	-4	-23	-65	-73	92	-142	-111	170	-250	-251	-215	-146
TTM Operating Income	-5	-4	-23	-65	-76	88	-149	-119	160	-263	-268	-231	-161
TTM Cash Flow to Firm	-2	-2	-22	-49	-58	105	-108	-53	243	-184	-212	-160	-79
TTM Free Cash Flow to Firm	-2	-2	-22	-40	-51	118	-96	-26	327	-154	-202	-158	-77

Multiples (USD)

Valuation Multiples API ChatGPT

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	-6.92	-12.12	-19.54	13.04	-15.66	-62.19	4.74	-5.54	-3.77	-2.24	-6.11
EV/EBIT	- -	- -	- -	- -	- -	13.64	- -	- -	6.44	- -	- -	- -	- -
Enterprise Value	11	14	323	402	880	1,201	1,231	1,297	1,030	712	605	230	576
Low Price	- -	- -	13.77	7.07	16.3	23.25	30.38	20.03	27.02	18.69	12.82	7.14	5.04
EV/Sales	1.75	2.27	42.52	87.51	84.65	5.5	34.93	8.39	2.19	6.32	6.7	2.76	3.38
EV/EBITDA	- -	- -	- -	- -	- -	13.05	- -	- -	6.07	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	14.03	- -	- -	10.86	- -	- -	- -	- -
Price/Earnings Average	- -	- -	-7.7	-5.66	-9.32	17.41	-17.35	-12.26	12.3	-4.04	-3.2	-2.98	-2.48
Price/Earnings High	- -	- -	-11.95	-10.3	-14.74	28.46	-24.48	-18.42	16.68	-5.5	-4.24	-6.28	-4.1
Price/Earnings Low	- -	- -	-5.14	-2.97	-6.66	7.78	-11.77	-6.71	8.97	-2.88	-2.13	-1.56	-1.34
Price/Book Value	- -	- -	2.01	3.04	5.69	2.98	3.37	4.5	1.83	1.9	2.54	1.48	7.13
Price/Book Value Average	- -	- -	2.5	2.21	3.9	3.7	3.68	3.63	2.08	2.2	2.72	2.61	4.61
Price/Book Value High	- -	- -	3.88	4.02	6.17	6.04	5.19	5.45	2.82	3	3.61	5.5	7.63
Price/Book Value Low	- -	- -	1.67	1.16	2.79	1.65	2.5	1.99	1.51	1.57	1.81	1.36	2.5
Price/Tangible Book Value	- -	- -	2.01	3.04	5.69	2.98	3.37	4.5	1.83	1.9	2.54	1.48	7.13
Price/Tangible Book Value Average	- -	- -	2.5	2.21	3.9	3.7	3.68	3.63	2.08	2.2	2.72	2.61	4.61
Price/Tangible Book Value High	- -	- -	3.88	4.02	6.17	6.04	5.19	5.45	2.82	3	3.61	5.5	7.63
Price/Tangible Book Value Low	- -	- -	1.67	1.16	2.79	1.65	2.5	1.99	1.51	1.57	1.81	1.36	2.5
Price/Sales	- -	- -	20.07	106.75	95.59	6.42	42.66	10.94	2.95	8.68	8.7	4.59	4.36
Price/Sales Average	- -	- -	24.92	77.67	65.65	7.96	46.65	8.82	3.34	10.06	9.34	8.13	2.82
Price/Sales High	- -	- -	38.68	141.28	103.78	13.02	65.82	13.26	4.53	13.68	12.38	17.11	4.66
Price/Sales Low	- -	- -	16.65	40.69	46.86	3.56	31.64	4.83	2.44	7.15	6.21	4.24	1.53
Price/Cash Flow	- -	- -	-6.76	-10.09	-17.13	13.4	-13.96	-31.28	6.34	-4.72	-3.59	-2.21	-5.99
Price/Cash Flow Average	- -	- -	-8.4	-7.34	-11.76	16.63	-15.26	-25.23	7.18	-5.46	-3.86	-3.91	-3.88
Price/Cash Flow High	- -	- -	-13.04	-13.35	-18.6	27.18	-21.53	-37.91	9.74	-7.43	-5.11	-8.24	-6.41
Price/Cash Flow Low	- -	- -	-5.61	-3.85	-8.4	7.43	-10.35	-13.81	5.24	-3.89	-2.57	-2.04	-2.1
Price/Free Cash Flow Average	- -	- -	-8.6	-8.82	-13.42	16.18	-17.12	-50.15	5.37	-6.41	-4.04	-3.97	-3.95
Price/Free Cash Flow High	- -	- -	-13.35	-16.04	-21.22	26.45	-24.16	-75.37	7.28	-8.72	-5.36	-8.35	-6.54
Price/Free Cash Flow Low	- -	- -	-5.74	-4.62	-9.58	7.23	-11.61	-27.46	3.92	-4.56	-2.69	-2.07	-2.14
EV/Sales Average	1.75	2.27	64.35	72.46	64.27	8.29	45.38	7.15	2.82	10.07	10.01	8.43	3.01
EV/Sales High	1.75	2.27	103.84	136.23	104.21	13.75	64.71	11.61	4.03	13.71	13.07	17.42	4.83
EV/Sales Low	1.75	2.27	40.62	35.38	44.59	3.52	30.24	3.14	1.91	7.16	6.86	4.54	1.73
EV/EBITDA Average	-2.24	-3.77	-21.18	-5.13	-9.13	19.66	-11.27	-9.97	7.84	-4.54	-3.6	-3.27	-3.52
EV/EBITDA High	-2.24	-3.77	-34.17	-9.65	-14.8	32.62	-16.07	-16.19	11.17	-6.18	-4.7	-6.75	-5.66
EV/EBITDA Low	-2.24	-3.77	-13.37	-2.51	-6.33	8.36	-7.51	-4.38	5.3	-3.23	-2.47	-1.76	-2.03
EV/EBIT Average	-2.24	-3.77	-21.11	-5.09	-8.8	20.55	-10.73	-9.27	8.3	-4.32	-3.37	-3.04	-3.18
EV/EBIT High	-2.24	-3.77	-34.05	-9.57	-14.27	34.1	-15.3	-15.05	11.84	-5.88	-4.4	-6.28	-5.11
EV/EBIT Low	-2.24	-3.77	-13.32	-2.48	-6.11	8.74	-7.15	-4.07	5.62	-3.07	-2.31	-1.64	-1.83
Last Price	- -	- -	16.6	18.55	33.25	41.95	40.97	45.36	32.7	22.68	17.95	7.73	14.4
High Price	- -	- -	32	24.55	36.1	85.1	63.21	54.97	50.26	35.73	25.54	28.8	15.41
Enterprise Value Average	11	14	488	333	668	1,811	1,599	1,105	1,328	1,135	904	702	513
Enterprise Value High	11	14	788	625	1,083	3,004	2,280	1,794	1,894	1,545	1,180	1,452	823
Enterprise Value Low	11	14	308	162	463	770	1,066	485	899	807	619	378	296

Shares Outstanding	25	25	26	26	31	36	37	37	43	43	44	50	51
Diluted Weighted Avg Shares	13	13	9	26	30	37	37	37	44	43	44	50	52
Basic Weighted Avg Shares	13	13	9	26	30	33	37	37	42	43	44	50	52
Revenue per Share	0.46	0.47	0.83	0.17	0.35	6.54	0.96	4.15	11.08	2.61	2.06	1.68	3.3
EBITDA per Share	-0.36	-0.28	-2.51	-2.45	-2.45	2.75	-3.87	-2.97	4	-5.79	-5.73	-4.34	-2.82
Operating Income per Share	-0.36	-0.28	-2.52	-2.47	-2.54	2.64	-4.06	-3.2	3.77	-6.09	-6.13	-4.67	-3.13
Basic EPS, GAAP	-0.44	-0.37	-2.68	-2.38	-2.45	2.99	-2.58	-2.98	3.01	-6.5	-6.02	-4.59	-3.76
Basic EPS from Cont Ops	-0.41	-0.3	-2.49	-2.38	-2.45	2.99	-2.58	-2.98	3.01	-6.5	-6.02	-4.59	-3.76
Diluted EPS, GAAP	-0.44	-0.37	-2.68	-2.38	-2.45	2.73	-2.58	-2.98	2.91	-6.5	-6.02	-4.59	-3.76
Diluted EPS from Cont Ops	-0.41	-0.3	-2.49	-2.38	-2.45	2.73	-2.58	-2.98	2.91	-6.5	-6.02	-4.59	-3.76
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.23	-0.18	-2.45	-1.84	-1.94	3.13	-2.94	-1.45	5.16	-4.81	-4.99	-3.5	-2.4
Free Cash Flow per Basic Share	-0.23	-0.18	-2.51	-2.15	-2.18	2.73	-3.25	-2.17	3.17	-5.52	-5.22	-3.55	-2.45
Cash & Equivalents per Share	0.05	0.05	4.34	3.38	5.14	8.85	8.01	12.69	10.68	8.42	6.25	4.74	4.52
Book Value per Share	-0.57	-0.74	8.24	6.11	5.85	14.09	12.17	10.08	17.84	11.92	7.08	5.24	2.02
Tangible Book Value per Share	-0.57	-0.74	8.24	6.11	5.85	14.09	12.17	10.08	17.84	11.92	7.08	5.24	2.02

REGENXBIO Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)